Kronos Bio Inc (KRON)

Dec 16, 2024

Layoff Tracker: Editas Will Cut 60% of Staff - BioSpace

Dec 16, 2024

Dec 06, 2024

Kronos Bio (NASDAQ:KRON) Trading 8.5% HigherHere's Why - MarketBeat

Dec 06, 2024

Dec 03, 2024

Struggling Bay Area biotech firm Kronos, once worth $1B, lays off almost entire staff - SFGATE

Dec 03, 2024

Dec 01, 2024

Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates - MSN

Dec 01, 2024

Dec 01, 2024

KRON (Kronos Bio) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com

Dec 01, 2024

Nov 29, 2024

A Look At The Behavior Of Kronos Bio Inc (KRON) Stock - Stocks Register

Nov 29, 2024

Nov 28, 2024

Kronos Bio announces interim CEO; over 80% of staff reduction - MSN

Nov 28, 2024

Nov 28, 2024

Kronos Bio announces interim CEO and workforce cuts of 83% - Yahoo Finance

Nov 28, 2024

Nov 28, 2024

Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN

Nov 28, 2024

Nov 28, 2024

Strategic shift at Kronos creates CEO vacancy - The Pharma Letter

Nov 28, 2024

Nov 27, 2024

Kronos Bio to lay off 83% of staff as CEO steps down - The Business Journals

Nov 27, 2024

Nov 27, 2024

Kronos Bio announces layoffs and executive changes By Investing.com - Investing.com Nigeria

Nov 27, 2024

Nov 27, 2024

Kronos Bio, Inc. Announces Management Changes, Effective December 3, 2024 - Marketscreener.com

Nov 27, 2024

Nov 27, 2024

Kronos Bio, Inc. Announces CEO Changes, Effective December 3, 2024 - Marketscreener.com

Nov 27, 2024

Nov 27, 2024

Kronos Bio Shakes Up LeadershipCuts 83% Of Workforce Amid Strategic Overhaul - AOL

Nov 27, 2024

Nov 27, 2024

Biotech with Cambridge lab slashes 83% of staff, CEO departs - NBC Boston

Nov 27, 2024

Nov 27, 2024

Kronos Bio announces layoffs and executive changes - Investing.com India

Nov 27, 2024

Nov 27, 2024

Kronos Bio Announces CEO Transition and Reduction in Force - The Manila Times

Nov 27, 2024

Nov 27, 2024

Kronos Bio stock in focus on CEO change, layoffs (KRON:NASDAQ) - Seeking Alpha

Nov 27, 2024

Nov 27, 2024

Kronos Bio to Cut 83% Of Workforce, Names Interim CEO - MarketWatch

Nov 27, 2024

Nov 27, 2024

Kronos Bio Cuts 83% of Workforce, Names New CEO Amid Strategic Review | KRON Stock News - StockTitan

Nov 27, 2024

Nov 27, 2024

Kronos Bio Restructures Workforce and Leadership - TipRanks

Nov 27, 2024

Nov 27, 2024

Kronos Bio : Management Change/Compensation Form 8 K - Marketscreener.com

Nov 27, 2024

Nov 27, 2024

Kronos, Idorsia plan layoffs; PTC shelves ALS drug - Yahoo Finance

Nov 27, 2024

Nov 26, 2024

KRON (Kronos Bio) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 21, 2024

Petri Dish: Kronos Bio seeks merger; Former Biogen R&D head joins investment firm - The Business Journals

Nov 21, 2024

Nov 20, 2024

Kronos Bio downgraded by Piper Sandler, TD Cowen - MSN

Nov 20, 2024

Nov 16, 2024

Kronos Bio Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 16, 2024

Nov 15, 2024

Kronos Bio Provides Update on Review of Strategic Alternatives - Marketscreener.com

Nov 15, 2024

Nov 15, 2024

Kronos Bio shares downgraded to hold by TD Cowen - Investing.com Australia

Nov 15, 2024

Nov 15, 2024

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024 - The Manila Times

Nov 15, 2024

Nov 14, 2024

Kronos Bio Highlights Preclinical Data that Show p300 KAT - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

Kronos Bio's KB-7898 Shows 50% Reduction in Inflammation Markers in Preclinical Study | KRON Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Kronos Bio stock takes a hit with piper sandler slashing price target - Investing.com

Nov 14, 2024

Nov 14, 2024

Kronos mulls ‘strategic alternatives’ after axing cancer drug development - Pharmaceutical Technology

Nov 14, 2024

Nov 14, 2024

Kronos Bio (NASDAQ:KRON) Rating Lowered to "Hold" at TD Cowen - MarketBeat

Nov 14, 2024

Nov 14, 2024

Kronos Bio downgraded by Piper Sandler, TD Cowen (NASDAQ:KRON) - Seeking Alpha

Nov 14, 2024

Nov 13, 2024

Kronos Bio earnings beat by $0.05, revenue topped estimates - Investing.com UK

Nov 13, 2024

Nov 13, 2024

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives - The Manila Times

Nov 13, 2024

Nov 13, 2024

Kronos Bio Reports Third Quarter 2024 Financial Results and - GlobeNewswire

Nov 13, 2024

Nov 13, 2024

Kronos Bio Halts Cancer Drug Trial, Explores Strategic Alternatives Amid Safety Concerns | KRON Stock News - StockTitan

Nov 13, 2024

Nov 10, 2024

Kronos Bio's Market Cap Drops To US$50m Leaving Insiders With Losses - Simply Wall St

Nov 10, 2024

Nov 07, 2024

Kronos Bio faces Nasdaq delisting over share price - Investing.com India

Nov 07, 2024

Nov 07, 2024

Kronos Bio faces Nasdaq delisting over share price By Investing.com - Investing.com UK

Nov 07, 2024